HK Stock MarketDetailed Quotes

01875 TOT BIOPHARM-B

Watchlist
  • 1.740
  • +0.060+3.57%
Market Closed Apr 29 16:08 CST
1.34BMarket Cap-32222P/E (TTM)

TOT BIOPHARM-B Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

TOT BIOPHARM-B Earnings Date

Currency: CNY

Period

FY2023 Annual Report

Mar 15, 2024

Revenue(YoY)

780.63M

+76.54%
EPS(YoY)

-0.05

+36.61%
Analyst Rating

No Data

TOT BIOPHARM-B Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Mar 24, 20222021/FY76.325M / 51.900M--
Mar 23, 20212020/FY22.491M / 53.213M--
Mar 17, 20202019/FY45.308M / 58.000M--
DatePeriodRevenue/EstimateEarnings Call
Mar 24, 20222021/FY76.325M / 51.900M--
Mar 23, 20212020/FY22.491M / 53.213M--
Mar 17, 20202019/FY45.308M / 58.000M--

TOT BIOPHARM-B Earnings Reports

  • TOT BIOPHARM-B: ANNUAL REPORT 2023

    Apr 26 06:01 ET

  • TOT BIOPHARM-B: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2023

    Mar 15 10:08 ET

  • TOT BIOPHARM-B: DATE OF BOARD MEETING

    Mar 5 03:43 ET

  • TOT BIOPHARM-B: INTERIM REPORT 2023

    Sep 21, 2023 05:20 ET

    • Read more

    Analysis

    Analyst Rating

    No Data

    Price Target

    No Data

    Heat List
    HK
    Overall
    Symbol
    Latest Price
    %Chg